Abstract:The development of therapeutic dosage (e.g. pharmaceutical) systems is an ongoing process which, in recent times has incorporated several emerging disciplines and themes at timely intervals. While the concepts surrounding dosage forms have developed and evolved, many polymeric excipients remain as the preferred choice of materials over existing counterparts, serving functions as matrix materials, coatings and providing other specific functional properties (e.g. adhesion, controlled release and mechanical properties). There have been, however, developments in the deployment of synthetic polymeric materials (e.g. polycaprolactone, poly lactic co-glycolic acid) when compared to naturally occurring materials (e.g. lactose, gelatin). Advances in pharmaceutical process technologies have also provided novel engineering platforms to develop a host of exciting structure based materials ranging from the nanometer to the macro scales. Some of these structure enabling technologies include spray drying, super critical processing, microfluidics and even wet chemical methods. More recently electrohydrodynamic (EHDA) engineering methods have emerged as robust technologies offering potential to fabricate a plethora of generic structures (e.g. particles, fibres, bubbles and pre-determined patterns) on a broad scale range. This review focuses on key developments using various EHDA technologies for the pharmaceutical and biomaterial remits when selecting synthetic and/or naturally occurring polymers as pharmaceutical (and therapeutic) excipients. In addition, the underlying EHDA process principles are discussed along with key parameters and variables (both materials and engineering). EHDA technologies are operational at ambient conditions and recent developments have also demonstrated their viability for large scale production. These are promising technologies which have potential in established (e.g. films, dressings and microparticles) and emerging scientific themes (e.g. nanomedicines and tissue engineering).

Fabrication of Patterned Polymer-Antibiotic Composite Fibers Via Electrohydrodynamic (ehd) Printing

Fabrication of Patterned Three-Dimensional Micron Scaled Core-Sheath Architectures for Drug Patches

Development of Random and Ordered Composite Fiber Hybrid Technologies for Controlled Release Functions

Co-printing of Vertical Axis Aligned Micron-Scaled Filaments Via Simultaneous Dual Needle Electrohydrodynamic Printing

A Novel Approach for Tailored Medicines: Direct Writing of Janus Fibers

Fabrication of Flexible Composite Drug Films Via Foldable Linkages Using Electrohydrodynamic Printing

Three-Dimensional Electrohydrodynamic Printing and Spinning of Flexible Composite Structures for Oral Multidrug Forms

Preparation of active 3D film patches via aligned fiber electrohydrodynamic (EHD) printing

Mass and controlled fabrication of aligned PVP fibers for matrix type antibiotic drug delivery systems

Fabrication of ampicillin/starch/polymer composite nanofibers with controlled drug release properties by electrospinning

Fabrication of Antimicrobial Multilayered Nanofibrous Scaffolds-Loaded Drug via Electrospinning for Biomedical Application

Combination techniques towards novel drug delivery systems manufacturing: 3D PCL scaffolds enriched with tetracycline-loaded PVP nanoparticles

Polymeric Based Therapeutic Delivery Systems Prepared Using Electrohydrodynamic Processes

Photodynamically Active Electrospun Fibres for Antibiotic-Free Infection Control

Engineering On‐Demand Magnetic Core–Shell Composite Wound Dressing Matrices Via Electrohydrodynamic Micro‐Scale Printing

Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system

Fabrication of 3D printed mutable drug delivery devices: a comparative study of volumetric and digital light processing printing

Development of Hybrid 3D-Printed Structure with Aligned Drug-Loaded Fibres Using In-Situ Custom Designed Templates

A Refined Hot Melt Printing Technique with Real-Time CT Imaging Capability.

Electrospun Polymer Blend Nanofibers for Tunable Drug Delivery: The Role of Transformative Phase Separation on Controlling the Release Rate

Fabrication of biodegradable hollow microsphere composites made of polybutylene adipate co-terephthalate/polyvinylpyrrolidone for drug delivery and sustained release